Price Cuts For Long-Listed Products “Absolutely Unacceptable” –Japan’s Top Drug Makers
This article was originally published in PharmAsia News
Executive Summary
Drug industry stakeholders in Japan told the Central Social Medical Insurance Agency (Chuikyo) Dec. 14 that they won’t accept a proposal of cutting branded generic drug prices.